[go: up one dir, main page]

MX2017015505A - Composicion de preparacion solida que contiene pranlukast con biodisponibilidad mejorada y metodo para preparar la misma. - Google Patents

Composicion de preparacion solida que contiene pranlukast con biodisponibilidad mejorada y metodo para preparar la misma.

Info

Publication number
MX2017015505A
MX2017015505A MX2017015505A MX2017015505A MX2017015505A MX 2017015505 A MX2017015505 A MX 2017015505A MX 2017015505 A MX2017015505 A MX 2017015505A MX 2017015505 A MX2017015505 A MX 2017015505A MX 2017015505 A MX2017015505 A MX 2017015505A
Authority
MX
Mexico
Prior art keywords
pranlukast
composition
solid preparation
containing solid
preparing same
Prior art date
Application number
MX2017015505A
Other languages
English (en)
Inventor
Hee LEE Kun-
Kim Su-Jin
Kil AHN Byeong
Man PARK Sang-
Youn Hwang Yong
Original Assignee
Sama Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57441544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2017015505(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sama Pharm Co Ltd filed Critical Sama Pharm Co Ltd
Publication of MX2017015505A publication Critical patent/MX2017015505A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica que contiene pranlukast y un método para preparar la misma. La presente invención tiene una velocidad de liberación y biodisponibilidad de pranlukast significativamente mejoradas comparadas con productos convencionales que contienen pranlukast.
MX2017015505A 2015-06-01 2016-06-01 Composicion de preparacion solida que contiene pranlukast con biodisponibilidad mejorada y metodo para preparar la misma. MX2017015505A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150077587A KR102363727B1 (ko) 2015-06-01 2015-06-01 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법
PCT/KR2016/005810 WO2016195377A2 (ko) 2015-06-01 2016-06-01 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법

Publications (1)

Publication Number Publication Date
MX2017015505A true MX2017015505A (es) 2018-05-11

Family

ID=57441544

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017015505A MX2017015505A (es) 2015-06-01 2016-06-01 Composicion de preparacion solida que contiene pranlukast con biodisponibilidad mejorada y metodo para preparar la misma.

Country Status (8)

Country Link
EP (1) EP3305282A2 (es)
JP (1) JP2018516942A (es)
KR (1) KR102363727B1 (es)
CN (1) CN108012526A (es)
BR (1) BR112017025793A2 (es)
MA (1) MA43122A (es)
MX (1) MX2017015505A (es)
WO (1) WO2016195377A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108686252B (zh) * 2018-06-11 2021-05-18 深圳英凡妮生物科技有限公司 一种以壳聚糖-泊洛沙姆为基质的纳米银抗菌敷料及其制备方法和应用
KR20240164596A (ko) 2023-05-09 2024-11-20 삼아제약 주식회사 복약편의성이 증진된 프란루카스트 함유 약제학적 조성물
KR20250015905A (ko) 2023-07-18 2025-02-03 삼아제약 주식회사 프란루카스트 함유 약제학적 조성물의 제조방법 및 상기 제조방법에 의해 제조된 약제학적 조성물
KR20250052834A (ko) 2023-10-12 2025-04-21 주식회사 다산제약 프란루카스트의 생체이용률이 개선된 약제학적 조성물 및 그 제조방법
KR20250074887A (ko) 2023-11-21 2025-05-28 대원제약주식회사 베포타스틴 및 프란루카스트를 함유하는 약제학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE230987T1 (de) 1995-06-12 2003-02-15 Ono Pharmaceutical Co Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast
KR101086254B1 (ko) 2004-11-04 2011-11-24 에스케이케미칼주식회사 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법
KR100957731B1 (ko) * 2005-04-11 2010-05-12 오노 야꾸힝 고교 가부시키가이샤 쓴맛이 저감된 프란루카스트 수화물을 함유하는 제제
KR100981751B1 (ko) * 2005-10-28 2010-09-10 주식회사유한양행 프란루카스트를 함유하는 과립 및 그의 제조방법
KR20080071557A (ko) * 2005-11-24 2008-08-04 오노 야꾸힝 고교 가부시키가이샤 고형 제제 및 제제 조성물
WO2007069378A1 (ja) * 2005-12-16 2007-06-21 Ono Pharmaceutical Co., Ltd. 薬物包装体
KR20110029249A (ko) * 2009-09-15 2011-03-23 김기탁 프란루카스트의 향상된 용해도를 갖는 약학적 조성물
KR101332223B1 (ko) 2011-09-19 2013-11-25 충남대학교산학협력단 프란루카스트 나노 고체 분산체의 제조방법 및 이로써 제조된 나노 고체 분산체
KR101446129B1 (ko) 2012-10-10 2014-10-06 조선대학교산학협력단 프란루카스트-함유 고형 제제의 제조방법

Also Published As

Publication number Publication date
CN108012526A (zh) 2018-05-08
MA43122A (fr) 2018-09-05
WO2016195377A2 (ko) 2016-12-08
JP2018516942A (ja) 2018-06-28
BR112017025793A2 (pt) 2018-08-07
KR20160141620A (ko) 2016-12-09
WO2016195377A3 (ko) 2017-01-26
EP3305282A2 (en) 2018-04-11
KR102363727B1 (ko) 2022-02-16

Similar Documents

Publication Publication Date Title
SI3313817T1 (sl) Biciklični derivati, postopek njihove priprave in farmacevtski sestavki, ki jih vsebujejo
MX2017015505A (es) Composicion de preparacion solida que contiene pranlukast con biodisponibilidad mejorada y metodo para preparar la misma.
EP3229791A4 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
MA40313A (fr) Composition pharmaceutique à base d'isotrétinoïne destinée à la voie orale
MX2020009444A (es) Composicion farmaceutica oral de isotretinoina con dosis baja y su proceso de preparacion.
HUP1500618A2 (en) Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical composition containing them
IN2014CH00840A (es)
MX2016015465A (es) Composicion farmaceutica oral de isotretinoina.
MA40447A (fr) Composition pharmaceutique orale d'isotrétinoïne
GB2555748B (en) Novel form of isoxadifen-ethyl, process for preparation and use thereof
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
IL260425B (en) New compounds of phosphinanes and azaphosphinanes, a process for their preparation and pharmaceutical compositions containing them
WO2015186139A3 (en) Novel polymorphs of tenofovir disoproxil oxalate and process for preparation of the same
IL267198B (en) Process for the preparation of powder preparations
IL262490A (en) Lomacaptor complexes and their salts and derivatives, a process for their preparation and pharmaceutical preparations containing them
IL262489A (en) Complexes of ivacaptor and its salts and their history, a process for their preparation and pharmaceutical preparations containing them
ZA201708190B (en) Process for the preparation of amphiphilic imidazolinium compounds
HK40012558B (zh) 制备粉末组合物的方法
HUP1400084A2 (hu) Dabigatran és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói
GR1008653B (el) Μεθοδος δια την παρασκευη πιπεροναλης
WO2015037017A3 (en) Pharmaceutical compositions of roflumilast and process for preparation thereof